Biomarker testing in non-small cell lung cancer is underutilized, hindering optimal treatment. Streamlined processes and ...

Biomarker testing for 11 oncogenes at diagnosis enables personalized lung cancer treatment, moving away from a one-size-fits-all approach. Biomarkers serve diagnostic, prognostic, and predictive roles ...

Source: Getty Images Despite proven benefits, biomarker tests remain underused in clinical practice. By examining genetic markers from urine or tissue samples, biomarkers provide a more precise ...

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE. “It definitely can change your treatment plan,” said Guinigundo. “With these estrogen ...

A panel held during the Institute for Value-Based Medicine event in Chicago on August 14, 2025, included discussions of access to biomarker testing and perioperative treatment in patients with ...

A cancer diagnosis can turn life upside down for patients and their families. Providers say advancements in biomarker testing can potentially improving patient outcomes. Biomarker testing can reveal ...

Cancer is often caused by genetic mutations, which can lead to abnormal cell growth in the body. One type is called the KRAS G12C mutation, which happens in the KRAS protein.[1] KRAS acts as the ...

Although treatment of advanced gastroesophageal cancer is increasingly dependent on biomarkers, only about 40% of patients are tested. For patients to fully benefit from the latest targeted therapies, ...

Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...

Cancer diagnosis used to be a simple, binary call: either someone had the disease or they didn’t. And patients with the same broad class of cancer tend to receive the same class of therapy. It was a ...